炎症性肠病的治疗轨迹和结果:三级单中心体验
Kim Wagner1, Tanja M Müller1,2, Francesco Vitali1
1Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Therapeutic advances in gastroenterology
|October 9, 2024
概括
现实数据显示,因弗利西马布仍然是炎症性肠病 (IBD) 治疗的主要选择,尽管其他生物药物正在上升. 随着后续的治疗线路,治疗的有效性下降,突出显示出需要更好的生物标志物.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 临床药理学 临床药理学
背景情况:
- 炎症性肠道疾病 (IBD) 的治疗环境正在多样化,这带来了治疗挑战.
- 未来的随机试验对现实世界治疗策略的洞察力有限.
- 现实世界的观察对于理解IBD当前的治疗方法至关重要.
研究的目的:
- 描述IBD转诊中心使用的现实世界治疗算法.
- 分析一大群IBD患者的治疗序列和患者结果.
主要方法:
- 对从502名克罗恩病 (CD) 和性结肠炎 (UC) 患者前性收集的数据进行了回顾性分析.
- 患者在德国的第三级推中心接受了infliximab,adalimumab,vedolizumab或ustekinumab的治疗.
- 治疗决策与患者的基线特征相关.
主要成果:
- 对于CD和UC,infliximab仍然是首选的第一线治疗方法.
- 随着时间的推移,乌斯特基努马布和维多利祖马布的使用在特定的适应症中增加了.
- 观察到的缓解率随着每次随后的治疗线下降.
结论:
- 在高等中心的现实世界治疗序列为指导IBD治疗选择提供了洞察力.
- 这项研究强调了对生物标志物的重大未满足需求,以支持IBD的治疗决策.
- 进一步的现实世界数据对于优化IBD管理中的治疗策略至关重要.
更多相关视频
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
01:21Inflammatory Bowel Disease V: Surgical Management
126
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
126
01:30Inflammatory Bowel Disease II: Crohn's Disease
191
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
191
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143